Access Vascular, Inc.

📙The 2024 INS Guidelines has multiple key recommendations related to catheter materials: "Improvements in catheter materials may reduce complications such as occlusion and thrombosis." We're proud to be at the forefront of material innovation with our novel MIMIX®️ catheter material designed to minimize these risks. Our commitment to better clinical outcomes with fewer complications aligns perfectly with these latest guidelines. Together, we can make a difference in patient care. 💙 To learn more about MIMIX technology, visit our website:https://loom.ly/5MhquwM #AccessVascular #INS2024 #MedicalInnovation #PatientSafety #CatheterTechnology

How could a 9️⃣9️⃣.9️⃣9️⃣% reduction in bacterial adhesion on your vascular access catheters improve your patient outcomes? The data presented at the Association for Vascular Access Annual Meeting in 2023 and the Infusion Nurses Society Annual Meeting in 2024 strongly supports MIMIX®️ technology in achieving this goal. We invite you to explore this compelling evidence and our multiple clinical studies. Please reach out at https://loom.ly/ElpFRfM *While in vitro data is valuable, it doesn’t always predict clinical outcomes. #vascularaccess #datadriven #patientoutcomes

We take pride in supporting new vascular access nurses as they hone their skills. Our dedicated clinical educators are always here to ensure your team feels confident in their vascular access abilities - whether inserting in these highly technical medical models 😉 or patients! #vascularaccess #nurseeducator #accessvascular #practicemakesperfect

We are looking forward to another great #AVASM24 Conference this year in Denver Colorado with the Association for Vascular Access! We would love to see you so be sure and stop by Booth 511! We are also scheduling individual demo sessions for our HydroMID/HydroPICC. Please reach out to us to schedule and mention AVA: https://loom.ly/gSt1u8E

🌟 Leading with Value-Based Care! At Access Vascular, our AVI Pledge program combines our revolutionary hydrophilic devices with comprehensive educational support and a robust performance guarantee to improve patient outcomes and reduce healthcare costs. Read our latest blog to learn how we’re transforming vascular access and supporting clinicians: https://loom.ly/Pjk7wDM #HealthcareInnovation #ValueBasedCare #AccessVascular #AVIpledge

After a pause due to COVID - Center for Medicare and Medicaid Services (CMS) Hospital Acquired Condition (HAC) penalties are back and impacting hospitals' bottom line. HAC Scores greater than the 75th percentile and therefore in the worst-performing quartile are subject to a 1% payment reduction. What tools are you implementing to protect the health of your patients and the financial health of your hospital? Check out the full 2024 HAC Penalty Information here: https://loom.ly/ZGv3GbE Access Vascular welcomes the opportunity to discuss our data with you and see if we might be able to help - read the latest on our website: https://loom.ly/ElpFRfM

AVI Founder and CEO, James Biggins, will be joining medtech’s leading innovators, investors and strategics at this year's LSI Europe '24. If you're attending in September, be sure to connect and learn more about how AVI is #tranformingvascularaccess. #LSIEurope24

With the high number of votes we received, we couldn’t choose just one winner for our Case Study Contest, so we’ve awarded the top two finalists! Congratulations to the authors of Case 1 featuring a HydroPICC Dual and Case 3 featuring a HydroMID. Each winner will receive $2,500 towards attendance at AVA. We want to extend a big thank you to everyone who submitted cases and everyone who cast their votes —seeing the submissions and the votes was exciting for the whole AVI family! This will be (at least) an annual event for AVI. Congratulations again, and be sure to check out the winning cases here: https://loom.ly/q_LvgB8 #datadriven #vascularaccess #AVA24 #accessvascular

Lee Steere, IV Nurse Manager at Hartford Hospital in Hartford, Connecticut, recently sat down with us and discussed what he sees as the impact of the new bacterial adhesion data. Changes to hospital-onset bacteremia are coming and a solution that has demonstrated with in vitro data to reduce bacterial adhesion by 99.99% may be a good option!* Visit https://loom.ly/ElpFRfM to learn more *In vitro data does not necessarily predict clinical results. Data presented at AVA 2023 and INS 2024. #vascularaccess #accessvascular #hospitaladministrator #infectionprevention

Last day to vote!! Now is the time to vote for our First Annual Case Study Contest with the winner receiving $2,500 towards attendance at the Association for Vascular Access Annual Meeting! We received so many great cases and narrowed it down to 6. Now we need YOU to vote for your favorite here: https://loom.ly/q_LvgB8 #accessvascular #vascularaccess